![]() |
市场调查报告书
商品编码
1497610
医疗保健人工智慧市场:按技术、服务、应用程式和最终用户划分 - 全球预测 2024-2030Artificial Intelligence in Healthcare Market by Technology (Computer Vision, Context-Aware Computing, Machine Learning), Offering (Hardware, Services, Software), Application, End User - Global Forecast 2024-2030 |
※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。
医疗保健领域人工智慧市场规模预计2023年为259.1亿美元,2024年达到324.8亿美元,预计2030年将达到1377.4亿美元,复合年增长率为26.95%。
医疗保健领域的人工智慧 (AI) 是使机器能够感知、理解、行动和学习的技术的集合。这包括可以处理医疗资料、预测结果、支持精准医疗和个人化患者照护的演算法和模型。推动人工智慧在医疗保健领域扩展的主要因素是医疗保健资料的大量增加、降低医疗成本上升的需要、计算能力的进步以及人工智慧演算法的改进。这些因素有助于提高治疗、药物发现和患者照护管理的效率。然而,资料安全问题、侵犯隐私的风险以及对人工智慧基础设施的大量投资的需求正在阻碍人工智慧的广泛普及。强有力的网路安全措施、人工智慧演算法的透明管治、持续的员工培训以及人工智慧系统的道德设计对于解决这些问题至关重要。利用人工智慧推进远端医疗、预测分析、开拓个人化治疗计划,以及将人工智慧与基因组学和医疗物联网 (IoMT) 等新兴技术相结合,预计将推动 Masu 市场的显着成长。
主要市场统计 | |
---|---|
基准年[2023] | 259.1亿美元 |
预测年份 [2024] | 324.8亿美元 |
预测年份 [2030] | 1377.4亿美元 |
复合年增长率(%) | 26.95% |
区域洞察
在大量技术投资、充满活力的Start-Ups生态系统以及鼓励数位医疗创新的政策倡议的推动下,美洲(尤其是美国)医疗保健领域的人工智慧市场正在蓬勃发展。美国是人工智慧诊断、远端监控和个人化医疗领域的先驱,科技巨头和人工智慧医疗保健专家正在推动进步。以中国和日本为代表的亚太地区政府对医疗保健创新给予大力支持,并正迅速拥抱人工智慧。鑑于人口众多以及改善医疗保健机会的动力,其使用往往侧重于大规模人口健康倡议和疾病模式分析。在亚太地区,由于国内新兴企业的激增和全球公司研发中心的扩张,生产变得越来越强劲。虽然欧洲在法律规范方面处于领先地位,并且 GDPR 影响了人工智慧的采用,但中东在智慧医院和人工智慧驱动的健康工具方面显示出巨大的成长潜力。儘管非洲仍处于采用的早期阶段,但它显示了行动医疗人工智慧应用在解决感染疾病和获得医疗服务方面的潜力。欧洲、中东和非洲地区的公司专注于开发合规和道德的人工智慧,一些领先公司提供先进的基于人工智慧的诊断成像和健康分析解决方案。
FPNV定位矩阵
FPNV 定位矩阵对于评估医疗保健市场人工智慧供应商的市场定位至关重要。此矩阵提供了对供应商的全面评估,并检查了与商务策略和产品满意度相关的关键指标。这种详细的评估使用户能够根据自己的要求做出明智的决定。根据评估结果,供应商被分为代表其成功程度的四个像限:前沿(F)、探路者(P)、利基(N)和重要(V)。
市场占有率分析
市场占有率分析是一种综合工具,可对医疗保健市场人工智慧供应商的现状进行深入而详细的评估。透过仔细比较和分析供应商的贡献,您可以更深入地了解每个供应商的绩效以及他们在争夺市场占有率时面临的挑战。这些贡献包括整体收益、客户群和其他重要指标。此外,该分析还提供了对该行业竞争性质的宝贵见解,包括在研究基准年期间观察到的累积、分散主导地位和合併特征等因素。有了这些详细信息,供应商可以做出更明智的决策并製定有效的策略,以在市场竞争中保持领先地位。
策略分析与建议
策略分析对于寻求在全球市场站稳脚跟的组织至关重要。对目前在医疗保健市场人工智慧中的地位进行全面评估,使公司能够做出符合其长期愿望的明智决策。此关键评估涉及对组织的资源、能力和整体绩效进行彻底分析,以确定核心优势和需要改进的领域。
[188 Pages Report] The Artificial Intelligence in Healthcare Market size was estimated at USD 25.91 billion in 2023 and expected to reach USD 32.48 billion in 2024, at a CAGR 26.95% to reach USD 137.74 billion by 2030.
Artificial intelligence (AI) in healthcare represents a collection of multiple technologies enabling machines to sense, comprehend, act, and learn so that they can perform administrative and clinical healthcare functions. It includes algorithms and models that are capable of processing medical data, predicting outcomes, aiding in precision medicine, and personalizing patient care. Major factors driving the expansion of AI in healthcare are the massive growth of healthcare data, the need to reduce escalating healthcare costs, advancements in computing power, and the improvement in AI algorithms. These factors contribute to enhancing the efficiency of treatments, drug discovery, and patient care management. However, data security concerns, the risk of privacy breaches, and the requirement for substantial investment in AI infrastructure impede their wide deployment. To address these issues, robust cybersecurity measures, transparent governance of AI algorithms, ongoing staff training, and the ethical design of AI systems are essential. The market is expected to witness significant growth by leveraging AI for telemedicine advancements, predictive analytics, the development of personalized treatment plans, and the integration of AI with emerging technologies such as genomics and the Internet of Medical Things (IoMT).
KEY MARKET STATISTICS | |
---|---|
Base Year [2023] | USD 25.91 billion |
Estimated Year [2024] | USD 32.48 billion |
Forecast Year [2030] | USD 137.74 billion |
CAGR (%) | 26.95% |
Regional Insights
In the Americas, especially the United States, there is a booming market for AI in healthcare, driven by heavy investments in technology, a vibrant startup ecosystem, and policy initiatives encouraging digital health innovation. The U.S. is a pioneer in AI-driven diagnostics, remote monitoring, and personalized medicine, with tech giants and specialized AI healthcare companies pushing advancements. The APAC region, led by countries such as China and Japan, is rapidly embracing AI, with significant government backing for healthcare technology innovation. The focus on use tends toward large-scale population health initiatives and disease pattern analysis, given the vast population and the drive towards improving healthcare accessibility. Production is increasingly robust in APAC, with a surge in homegrown startups and expanded R&D centers from global companies. Europe leads in regulatory frameworks with GDPR impacting AI deployment, whereas the Middle East shows considerable growth potential with smart hospitals and AI-powered health tools. Africa is still in the early adoption stages, but it shows potential in mobile health AI applications that address infectious diseases and access to medical services. Companies in EMEA are focused on compliance and ethical AI development, with some leading enterprises offering advanced AI-based imaging and health analytics solutions.
Market Insights
The market dynamics represent an ever-changing landscape of the Artificial Intelligence in Healthcare Market by providing actionable insights into factors, including supply and demand levels. Accounting for these factors helps design strategies, make investments, and formulate developments to capitalize on future opportunities. In addition, these factors assist in avoiding potential pitfalls related to political, geographical, technical, social, and economic conditions, highlighting consumer behaviors and influencing manufacturing costs and purchasing decisions.
FPNV Positioning Matrix
The FPNV positioning matrix is essential in evaluating the market positioning of the vendors in the Artificial Intelligence in Healthcare Market. This matrix offers a comprehensive assessment of vendors, examining critical metrics related to business strategy and product satisfaction. This in-depth assessment empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success, namely Forefront (F), Pathfinder (P), Niche (N), or Vital (V).
Market Share Analysis
The market share analysis is a comprehensive tool that provides an insightful and in-depth assessment of the current state of vendors in the Artificial Intelligence in Healthcare Market. By meticulously comparing and analyzing vendor contributions, companies are offered a greater understanding of their performance and the challenges they face when competing for market share. These contributions include overall revenue, customer base, and other vital metrics. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With these illustrative details, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.
Recent Developments
GE HealthCare Launches AI-Powered Innovations to Shape the Future of Healthcare
GE HealthCare introduced 19 advanced innovations in AI-enhanced systems, including the Omni Legend PET/CT scanner for impeccable diagnostic accuracy and the patient-centric SIGNA Champion MRI, which are poised to redefine diagnostic processes and patient experiences. Additionally, clinic workflow efficiency is anticipated to soar with GE's Portrait VSM and the portable yet powerful Vscan Air SL for rapid cardiac and vascular assessments. [Published On: 2024-01-29]
HEALWELL AI to Acquire Intrahealth to Create Next Generation AI-powered EHR
HEALWELL AI Inc. announced its acquisition of Intrahealth Systems Limited from WELL Health Technologies Corp. With Intrahealth's substantial professional network and its forecast to produce significant revenue and high gross margins in 2024, the acquisition promises to be a transformative combination for delivering advanced clinical decision support and shaping the trajectory of value-based care globally. [Published On: 2024-01-25]
HEALWELL AI Completes Acquisition of 'Pentavere,' a Healthcare AI and Data Science Company
HEALWELL AI Inc. enriched its portfolio by acquiring a significant stake in Pentavere Research Group Inc., a Toronto-based pioneer in health-tech AI. Through this strategic move, HEALWELL incorporates Pentavere's technology for data abstraction and structuring, reinforcing its mission to enhance preventative care. [Published On: 2023-12-04]
Strategy Analysis & Recommendation
The strategic analysis is essential for organizations seeking a solid foothold in the global marketplace. Companies are better positioned to make informed decisions that align with their long-term aspirations by thoroughly evaluating their current standing in the Artificial Intelligence in Healthcare Market. This critical assessment involves a thorough analysis of the organization's resources, capabilities, and overall performance to identify its core strengths and areas for improvement.
Key Company Profiles
The report delves into recent significant developments in the Artificial Intelligence in Healthcare Market, highlighting leading vendors and their innovative profiles. These include Ada Health GmbH, AiCure, LLC, AllStripes Research Inc., Aspen Technology Inc. by Emerson Electric Co., Atomwise Inc., Augmedix, Inc., Babylon Healthcare Services Ltd., Behold.ai Technologies Limited, Binah.ai, BioSymetrics Inc., BPGbio Inc., Butterfly Network, Inc., Clarius Mobile Health Corp., Clinithink Limited, ClosedLoop.ai Inc., Corti ApS, Cyrcardia Asia Limited, Datature.io, Deep Genomics Incorporated, Diabeloop SA, Enlitic, Inc., GE Healthcare, General Vision Inc., Google, LLC by Alphabet, Inc., iCarbonX, Intel Corporation, International Business Machines Corporation, Koninklijke Philips N.V., Medasense Biometrics Ltd., Microsoft Corporation, Modernizing Medicine, Inc., Nanox Imaging Ltd., NetBase Quid, Inc., Novo Nordisk A/S, NVIDIA Corporation, Oncora Medical, Oracle Corporation, Owkin, Inc., Oxipit.ai, R1 RCM, Inc., Recursion Pharmaceuticals, Sanofi SA, Sensely, Inc., Shanghai Yitu Technology Co., Ltd., Siemens Healthineers AG, SkinvVision B.V., Subtle Medical, Inc., Tempus Labs, Inc., Turbine Ltd., and Woebot Health.
Market Segmentation & Coverage